Abstract
To evaluate the use of HSV-based vectors for arthritis gene therapy we have constructed a first-generation, ICP4 deficient, replication defective herpes simplex virus (HSV) vector (S/0−) and a second-generation HSV vector derivative (T/0−) deficient for the immediate–early genes ICP4, 22 and 27, each carrying a soluble TNF receptor or IL-1 receptor antagonist transgene cassette. A rabbit synovial-fibroblast line in culture, infected by either vector enabled high-level expression of the transgene product. However, following a single intra-articular injection of the vectors into rabbit knee joints, only the second-generation, HSV T/0− vector expressed detectable levels of soluble TNFR in synovial fluid. Synovial lavage fluid from inoculated joints con- tained up to 12 ng/ml of soluble receptor that persisted at detectable, but reduced levels for at least 7 days. When tested in an experimental model of arthritis generated by intra-articular overexpression of interleukin-1β using retrovirus transduced synovial cells, the HSV T/0− vector expressing the interleukin-1 receptor antagonist was found to inhibit leukocytosis and synovitis significantly. The improved levels and duration of intra-articular transgene expression achieved via HSV-mediated gene delivery suggest that an HSV vector system could be used for therapeutic applications in patients with rheumatoid arthritis (RA) and other joint-related inflammatory diseases.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.gt.3301014/MediaObjects/41434_1999_Article_BF3301014_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.gt.3301014/MediaObjects/41434_1999_Article_BF3301014_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.gt.3301014/MediaObjects/41434_1999_Article_BF3301014_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.gt.3301014/MediaObjects/41434_1999_Article_BF3301014_Fig4_HTML.jpg)
Similar content being viewed by others
References
Evans CH et al. Gene therapy in autoimmune diseases Ann Rheum Dis 1998 57: 125–127
Evans CH et al. Gene therapy for rheumatic diseases Arthritis Rheum 1999 42: 1–16
Bandara G et al. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer Proc Natl Acad Sci USA 1993 90: 10764–10768
Hung G et al. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium Gene Therapy 1994 1: 64–69
Otani K et al. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy J Immunol 1996 156: 3558–3562
Evans CH et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis Hum Gene Ther 1996 7: 1261–1280
Ghivizzani SC et al. Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy Gene Therapy 1997 4: 977–982
Nita I et al. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo Arthritis Rheum 1996 39: 820–828
Roessler BJ et al. Adenoviral-mediated gene transfer to rabbit synovium in vivo J Clin Invest 1993 92: 1085–1092
Yovandich J et al. Gene transfer to synovial cells by intra-articular administration of plasmid DNA Hum Gene Ther 1995 6: 603–610
Tomita T et al. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes Arthritis Rheum 1997 40: 901–906
Ghivizzani SC et al. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects Proc Natl Acad Sci USA 1998 95: 4613–4618
Evans CH, Ghivizzani SC, Robbins PD . Blocking cytokines with genes J Leukocyte Biol 1998 64: 55–61
Glorioso JC et al. Progress in the development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis Adv Drug Del Rev 1997 27: 41–57
Campbell MEM, Palfeyman JW, Preston CM . Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription J Mol Biol 1984 180: 1–19
Mackem S, Roizman B . Differentiation between alpha promoter and regulatory regions of herpes simplex virus type 1: the functional domains and sequence of a movable alpha regulator Proc Natl Acad Sci USA 1982 79: 4917–4921
DeLuca NA, McCarthy AM, Schaffer PA . Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate–early regulatory protein ICP4 J Virol 1985 56: 558–570
DeLuca NA, Schaffer PA . Activation of immediate–early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4 Mol Cell Biol 1985 5: 1997–2008
Krisky DM et al. Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons Gene Therapy 1998 5: 1593–1603
Georgescu HI, Mendelow D, Evans CH . An established cell line from rabbit periarticular soft tissue which retains the ‘activatable’ phenotype In Vitro 1988 24: 1015–1022
Ghivizzani SC et al. Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis J Immunol 1997 159: 3604–3612
Roessler B et al. Inhibition of interleukin-1 induced effects in synoviocytes transduced with human IL-1 receptor antagonist cDNA using an adenviral vector Hum Gene Ther 1995 6: 307–316
Samaniego LA, Neiderhiser L, DeLuca NA . Persistence and expression of the herpes simplex virus genome in the absence of immediate–early proteins J Virol 1998 72: 3307–3320
Fisher KJ et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis Virology 1996 217: 11–22
Kochanek S et al. A new adenoviral vector: replacement of all viral coding sequences with 28kb of DNA independently expressing both full-length Dystrophin and β-galactosidase Proc Natl Acad Sci USA 1996 93: 5731–5736
Krisky DM et al. Rapid method for construction of recombinant HSV gene transfer vectors Gene Therapy 1997 4: 1120–1125
Peppel K, Crawford D, Beutler B . A tumor necrosis factor (TNF) receptor-Ig heavy chain chimeric protein as a bivalent antagonist of TNF activity J Exp Med 1991 174: 1483–1489
McGeoch DJ et al. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1 J Gen Virol 1988 69: 1531–1574
Acknowledgements
This work was supported by National Institute of Health grants NIH-NIAMS-96–1 (PDR) and 5R01 AR44526–02 (JCG).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oligino, T., Ghivizzani, S., Wolfe, D. et al. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther 6, 1713–1720 (1999). https://doi.org/10.1038/sj.gt.3301014
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301014
- Springer Nature Limited